# Safety and Feasibility of HIPEC for High-Risk Gallbladder Adenocarcinoma

> **NCT05430035** · EARLY_PHASE1 · RECRUITING · sponsor: **West Virginia University** · enrollment: 10 (estimated)

## Conditions studied

- Gallbladder Adenocarcinoma

## Interventions

- **DRUG:** HIPEC

## Key facts

- **NCT ID:** NCT05430035
- **Lead sponsor:** West Virginia University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-23
- **Primary completion:** 2027-12
- **Final completion:** 2029-07
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05430035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05430035, "Safety and Feasibility of HIPEC for High-Risk Gallbladder Adenocarcinoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05430035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*